Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Profusa Inc

PFSA ✓ COMPLIANTFree checks used up today ☆ Track — members

NASDAQ · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Micro Cap Analyst: N/A

Last Close

$1.02

▲ +20.11%

Market Cap $617.76K · Vol 2.43M

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$617.76K

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

20.40

Momentum

Beta

N/A

vs Market

52W High

$3,000.00

99.97% below

52W Low

$0.76

11.74% above

Volume

2.43M

Avg 371.20K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

58.29%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Profusa Inc (PFSA) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PFSA pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-4.67%

-53.00%

-86.58%

-98.39%

YTD

-99.87%

-99.95%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	N/A
Net Income	N/A
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	N/A · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	605.65K

Technical Indicators

50-Day SMA	$3.18
200-Day SMA	$115.49
RSI (14)	20.40
Beta	N/A
52-Week High	$3,000.00
52-Week Low	$0.76

Volume Today	2.43M
Avg Daily Volume (30D)	371.20K
Relative Volume	6.56x
Volatility (10D)	145.05
Volatility (30D)	237.55
Free Float	58.29%

Analyst Consensus

N/A

Current Price $1.02

Mean Target N/A

52W Low$0.76 52W High$3,000.00

Current

Target

$0.76 $3,000.00

Current Analyst target

· 0 analysts

Identifiers

ExchangeNASDAQ

FIGIN/A

ISINUS74319X4051

CountryUSA

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories +1.99% MDT Medtronic PLC +3.83% COR Cencora, Inc. -0.57% 7741.T HOYA CORPORATION -0.47% BDX Becton Dickinson and Co +3.13%

Company Profile

Profusa, Inc. is a commercial stage digital health company. The Company is engaged in the development of a new generation of biointegrated sensors that potentially empower the individual with the ability to monitor their body chemistry. The Company’s technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. Its first clinical offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels in various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds (diabetic ulcers, pressure sores) that do not heal properly; and reconstructive surgery.